Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2013 066 906.6 |
96 | EP file number | EAKZ | 13 19 4485.2 |
97 | EP publication number | EPN | 2875817 |
54 | Designation/title | TI | Pharmazeutische Formulierung enthaltend amorphes Lenalidomid |
51 | IPC main class | ICM (ICMV) | A61K 31/454 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/16 (2006.01) |
22 | DE application date | DAT | Nov 26, 2013 |
96 | EP application date | EAT | Nov 26, 2013 |
43 | Date of first publication | OT | May 27, 2015 |
| Date of publication of grant | PET | Mar 18, 2020 |
71/73 | Applicant/owner | INH | Synthon B.V., Nijmegen, NL |
72 | Inventor | IN | Van Eupen, Jacobus Theodorus Henricus, 6545CM Nijmegen, NL; Keltjens, Rolf, 6545CM Nijmegen, NL; Murpani, Deepak, 6545CM Nijmegen, NL |
| Address for service | | Synthon B.V., 6503 GN Nijmegen, NL |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002875817 Searchable text:
EP000002875817 Original document:
EP000002875817B1 Searchable text:
EP000002875817B1 |
43 | Date of first publication | EVT | May 27, 2015 |
| Date of the first transfer into DPMAregister | EREGT | May 28, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 29, 2021 (Show all update days)(Hide all update days)- Jul 29, 2021; Jul 16, 2021; Feb 18, 2021; Feb 4, 2021; Apr 9, 2020; Mar 4, 2020; Feb 27, 2020; Sep 19, 2019; Jan 12, 2017
- Historical data not available for this/these date(s)
- May 28, 2015
- Date of the first transfer into DPMAregister
|